A prospective feasibility study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer
Not Applicable
Completed
- Conditions
- on-small cell lung cancerNon-small cell lung cancerCancer - Lung - Non small cell
- Registration Number
- ACTRN12613000061730
- Lead Sponsor
- Peter MacCallum Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age greater than or equal to 18 years.
Written informed consent has been provided.
FDG-PET scan performed for cancer staging.
Patients receiving curative intent radiotherapy for non-small cell lung cancer.
Minimum dose of radiotherapy prescribed is 60Gy with or without chemotherapy
ECOG performance status 0-2 inclusive
Exclusion Criteria
Participant is not able to tolerate supine position on PET/CT bed for the duration of the PET/CT acquisitions, is not cooperative, or needs continuous nursing (e.g. patient from Intensive Care Unit).
Pregnancy
Breast-feeding
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method